Property:Results during intervention
This is a property of type Text.
C
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
NA +
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
NA +
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
NA +
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
NA +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
4 month after therapy start:
Significant increase in positive tests in the Carnitin + Sildenafil Arm compared to Baseline (36.4% vs. 63.6%; p < 0.01) +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
Carnitin + Sildenafil Arm and Sildenafil + Placebo Arm had significantly more side effects than the Placebo Arm (χ² = 18.786; p < 0.01), but no difference between the intervention arms +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
4 month after therapy start:
No significant differences between or significant changes within the arms +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
4 month after therapy start:
Higher satisfaction in the Carnitin-Sildenafil Arm (87.5%) compared to the Sildenafil + Placebo Arm (51.3%; p < 0.05) and in the Sildenafil + Placebo Arm compared to the Placebo Arm (6.8%; p < 0.01) +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
4 month after therapy start:
Carnitin + Sildenafil Arm significantly better than Sildenafil + Placebo Arm, and Sildenafil + Placebo Arm better than Placebo Arm in domains: Erectile Function (Mean(SD) = 27.3 (4.6) > 21.7 (6.8) > 11.7 (3.7)), Satisfaction with Sexual Activity (8.9 (4.7) > 4.8 (2.5) > 3.1 (0.6)), Orgasm (8.8 (2.6) > 5.9 (2.9) > 3.0 (0.6)), and General Sexual Well-Being (8.6 (2.0) > 5.4 (2.7) > 2.8 (0.7); p = not given) +
Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer +
NI +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
NA +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
NA +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
NA +
Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial +
NI +
Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial +
NI +
Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer +
Per arm:
* Poly E 600 arm: 27% grade II weight gain (day 138 on study drug), grade III indigestion (day 40), grade III insomnia (day 6)
* Poly E 400 arm: 6.25% grade III rectal bleeding (day 18)
* Poly E 800 arm: 33% grade III alanine aminotransferase (ALT) elevation (day 91)
Rectal bleeding occurred in a woman with pre-existing diverticulosis and required hospitalization; after this serious adverse event, the protocol was amended to exclude women with a prior history of a gastrointestinal bleed. +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
After 2 weeks (end of phase I, ITT-Analysis and PP-Analysis): No differences between arms and/or time points +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
After 2 weeks (end of phase I, ITT-Analysis and PP-Analysis): No differences between arms and/or time points +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
After 2 weeks (end of phase I, ITT-Analysis and PP-Analysis): No differences between arms and/or time points +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
After 2 weeks (end of phase I, ITT-Analysis and PP-Analysis): No differences between arms and/or time points +